张剑清是一名上海交通大学在读博士生，获中国人工智能学会「青托 」 、吴文俊人工智能荣誉博士及国家奖学金。在代码大模型、 合成数据集进化生成、联邦学习与推荐系统方向取得系列成果，主要关注其中的垂域自适应、模型融合、模型个性化主题，于 JMLR、NeurIPS、ICML、CVPR、KDD、ICCV、AAAI等发表9篇CCF-A一作论文，主导并开源了PFLlib、HtFLlib、EvolveGen 等项目，曾在字节跳动、清华AIR、KAUST、腾讯等机构实习交流。 数据短缺问题随着大模型的高速发展，日益加剧。已经有不少 Nature 论文指出，预计到 2028 年，公共数据的产生速度将因 赶不上大模型训练的消耗速度而被耗尽。而在某些特殊领域，比如医疗、工业制造等，原本可用数据就非常少，数据短缺的问 题更严重。 为了解决这一困境，我们提出了合成数据自主进化框架 PCEvolve：只需提供少量标注样本，就可在保护隐私同时进化出一整 个数据集。PCEvolve 的进化过程类似 DeepMind 提出的 FunSearch 和 AlphaEvolve。 现有大模型 API 并不能拿来直接合成垂域数据 然而，当应用到垂直领域 ...

Group 1: Boeing's Contract and Market Position - Boeing recently secured a contract valued at $2.84 billion for the Evolved Strategic Satellite (ESS) program, which is expected to be completed by December 31, 2033 [2][9] - The contract involves the development and production of four ESS space vehicles, enhancing capacity, flexibility, reliability, and resilience compared to existing strategic communications satellites [2][4] - Boeing's extensive experience in supporting major U.S. space missions positions the company favorably in the growing space technology market, particularly with the increasing demand for satellite deployment [3][4] Group 2: Industry Growth and Opportunities - The global space launch vehicles market is projected to grow at a compound annual growth rate of 18.4% from 2025 to 2030, driven by technological advancements and rising investments in space infrastructure [3] - Other companies benefiting from this market expansion include Northrop Grumman, which has a long-term earnings growth rate of 3.3% and is involved in launch vehicles and propulsion systems [5][6] - Rocket Lab is also positioned well with its advanced Electron rocket and the development of the Neutron rocket, expecting a year-over-year sales growth of 32.8% in 2025 [7][8] Group 3: Boeing's Stock Performance - Boeing's stock has increased by 27.3% over the past six months, outperforming the industry average growth of 22% [11] - The company currently holds a Zacks Rank of 3 (Hold), indicating a stable outlook in the market [12]

证券研究报告：金融工程报告 发布时间：2025-07-08 研究所 分析师:肖承志 SAC 登记编号:S1340524090001 Email:xiaochengzhi@cnpsec.com 研究助理:冯昱文 SAC 登记编号:S1340124100011 Email:fengyuwen@cnpsec.com 近期研究报告 《低估值高盈利，基本面表现占优—— 中 邮 因 子 周 报 20250706 》 - 2025.07.07 《基于宏观经济状态划分的 BL 模型与 ETF 实践》 - 2025.07.01 《反转风格显著，小市值回撤——中 邮因子周报 20250622》 - 2025.06.23 《关注基本面支撑，高波风格占优— —中邮因子周报 20250615》 - 2025.06.16 《结合基本面和量价特征的 GRU 模 型》 - 2025.06.05 《Claude 4 系列发布，谷歌上线编程 智能体 Jules——AI 动态汇总 20250526》 - 2025.05.27 《谷歌发布智能体白皮书，Manus 全面 开放注册——AI 动态汇总 20250519》 - 2025.05.20 《证监 ...

Core Points - SenesTech, Inc. announced the closing of the exercise of outstanding warrants to purchase 1,458,872 shares of common stock at an exercise price of $2.90 per share, generating approximately $4.4 million in gross proceeds [1][4] - The company issued new unregistered short-term warrants for the same number of shares at an exercise price of $4.15 per share, with a purchase price of $0.125 per warrant, potentially raising an additional $6.0 million if fully exercised [3][4] - The net proceeds from the transaction are intended for working capital and general corporate purposes [4] Company Overview - SenesTech is focused on humane management of animal pest populations through fertility control, having developed products like ContraPest®, the only U.S. EPA-registered contraceptive for rats, and Evolve™ products for rodents [8]

SURPRISE, Ariz., July 1, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on March 11, 2025, at the existing exercise price of $2.90 per share. The closing of the warrant exercise transactio ...

RTX TodayRTXRTX$146.17 +1.51 (+1.04%) 52-Week Range$99.07▼$149.26Dividend Yield1.86%P/E Ratio42.87Price Target$161.12Add to WatchlistThe global market is currently defined by two powerful and distinct currents: rising geopolitical instability and a resilient demand for commercial air travel. Few companies are built to navigate both of these worlds, but RTX Corporation NYSE: RTX is uniquely structured to do so. The aerospace and defense giant operates under a dual mandate, serving governments that are build ...

Core Insights - RTX Corporation's Raytheon segment secured a $250 million contract with Mitsubishi Electric Corporation to produce Evolved Seasparrow Missile (ESSM) Block 2, enhancing Japan's defense manufacturing capabilities [1][9] - Following the announcement, RTX's share price increased by 0.58% to $142.67 [2] - The global missiles and missile defense systems market is projected to grow at a CAGR of 5% from 2025 to 2030 due to rising geopolitical tensions [3] Company Overview - RTX is recognized for its advanced missile defense systems, leveraging innovative technology such as sensors, radars, and interceptors, which solidifies its leadership in the market [4] - The ESSM Block 2 missile features improved mobility and performance, reducing reliance on shipboard illumination and integrating with various combat systems [5][9] - RTX's product portfolio includes several combat-proven missiles, such as the SM-6, Patriot Guidance Enhanced Missile, and Tomahawk Cruise Missile [6] Industry Opportunities - Other defense companies like Boeing, Northrop Grumman, and Lockheed Martin are also positioned in the advanced missile systems market, with Boeing showing a long-term earnings growth rate of 18.1% and Lockheed Martin at 10.5% [7][8][10] - Northrop Grumman focuses on high-speed, long-range strike weapons, while Lockheed Martin develops advanced missiles and rockets [8][10] Stock Performance - Over the past six months, RTX shares have increased by 23.8%, outperforming the industry growth of 18.2% [11]

Pallet and Container Orders Expected for Resupply and ExpansionSURPRISE, Ariz., June 26, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, today announced compelling results from two major urban deployments — one in Hong Kong and one in San Francisco — showing how pairing Evolve™ Rat Birth Control with traditional poison bait stations delivers faster, more sustainable rodent control where it's needed most.Gl ...

"This project highlights how community-driven action and science-based solutions can work together to support sustainability," said Joel Fruendt, President and CEO of SenesTech. "Evolve aligns with these goals by providing a non-lethal, poison-free solution to rodent control." Evolve was deployed across 267 bait stations previously containing rodenticides and snap traps. According to field observations, rats consumed 98% of Evolve across all stations each month, indicating high acceptance and performance of ...

ARK: Survival Evolved sees over 3,000% sales lift in June Snail leverages box office and music partnerships to promote ARK: Aquatica CULVER CITY, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Snail, Inc. (Nasdaq: SNAL) ("Snail Games" or the "Company"), a leading global independent developer and publisher of interactive digital entertainment, celebrates the ARK franchise's 10-year anniversary with strong June 2025 sales momentum across ARK: Survival Evolved ("ASE") and it launches targeted marketing strategy to ...